NEAM
GCVRZ

New England Asset Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

New England Asset Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-2,000
Closed – – 155
2015
Q3 		$0 Hold
2,000
– – ﹤0.01% 166
2015
Q2 		$1K Hold
2,000
– – ﹤0.01% 160
2015
Q1 		$1K Hold
2,000
– – ﹤0.01% 173
2014
Q4 		$2K Hold
2,000
– – ﹤0.01% 140
2014
Q3 		$1K Hold
2,000
– – ﹤0.01% 144
2014
Q2 		$1K Hold
2,000
– – ﹤0.01% 144
2014
Q1 		$1K Hold
2,000
– – ﹤0.01% 125
2013
Q4 		$1K Hold
2,000
– – ﹤0.01% 125
2013
Q3 		$4K Hold
2,000
– – ﹤0.01% 128
2013
Q2 		$4K Buy
+2,000
New +$3.51K ﹤0.01% 131

Other funds holding GCVRZ

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

New England Asset Management's GCVRZ Position: Q4 2015 in Review

New England Asset Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2015, closing a stake of 2,000 shares.

New England Asset Management first reported a position in GCVRZ in Q2 2013 and held it in 10 quarters. The position peaked at $4K in Q3 2013. 114 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2015.

  • New England Asset Management reported no remaining Sanofi Contingent Value Rights position as of Q4 2015 after selling out during the quarter.
  • New England Asset Management sold 2,000 Sanofi Contingent Value Rights shares in Q4 2015.
  • New England Asset Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 10 quarters.
  • New England Asset Management's Sanofi Contingent Value Rights position peaked at $4K in Q3 2013.
  • 114 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2015.

Based on New England Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.